Improving the treatment of high-risk acute leukaemia [ 2014 - ]

Research Grant

Researchers: Prof Richard Lock (Principal investigator)

Brief description Recent research has focussed on molecular characterisation of high-risk acute leukaemia subtypes. This proposal will combine the power of genomic analysis, global analysis of protein kinases and stringent preclinical drug testing in order to improve the treatment of these high-risk acute leukaemia subtypes. Several innovative and interrelated projects within this Program will utilise a unique and clinically relevant experimental model to achieve their goals.

Funding Amount $601,420.00

Funding Scheme Research Fellowships

Notes Research Fellowship